The Food and Drug Administration approved the drug, called Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. It's taken once a day for 14 days.
FDA Approves First Pill for Postpartum Depression
FDA Approves First Ever Drug to Treat Postpartum Depression - The Lab World Group
Curious Bioethics: July 31-August 6, 2023
New hope for postpartum depression: FDA approves first pill to treat it
A New Dawn for Mothers: FDA Approves First Pill for Postpartum Depress – Preggo Leggings
First postpartum depression pill approved by FDA: What to know, Brain, Your Pregnancy Matters
FDA approves pill for postpartum depression - Good Morning America
FDA Approves First Drug for Postpartum Depression
The first pill for postpartum depression gives a psychiatrist hope
FDA approves first pill for treatment of postpartum depression - CBS News
FDA sets a decision date for Sage's postpartum depression pill - The Boston Globe
FDA approves first postpartum depression pill in the US
FDA Approved First Pill Designed For Postpartum Depression
